Recall: D-0051-2027

Class II - Potentially Harmful

Class IIClassification
2026-09-29Initiated
OngoingStatus
PfizerFirm

Product

Levoxyl (levothyroxine sodium tablets, USP), tablets, 175 mcg, 1000-count bottle, Rx only, Distributed by Pfizer Inc., New York, NY 10017, Made in Austria. NDC 60793-859-10

Reason

Subpotent Drug: confirmed out-of-specification (OOS) assay during stability testing.

Distribution

US Nationwide and Puerto Rico

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.